Keurig Must Face Trial Over Claims It Monopolized K-Cup Market and Kept Prices High

Keurig Green Mountain must face trial over claims that it used exclusive contracts and other business practices to keep rival coffee pods out of the K-Cup market and preserve higher prices after key patents protecting its brewing system expired.

The long-running antitrust litigation dates back more than a decade, with the remaining plaintiffs in the older consolidated cases collectively seeking more than $1.5 billion in damages.

U.S. District Judge Vernon S. Broderick found enough disputed evidence to send several of the plaintiffs’ core antitrust claims to a jury. His 139-page summary judgment ruling allows monopolization, exclusive-dealing, tying, and certain false-advertising allegations to continue while cutting several other theories from the case. Keurig’s liability and any alleged overcharges remain unresolved.

The dispute traces back to 2012, when key patents covering the K-Cup system expired. Until then, patent law gave Keurig the legal right to exclude competitors from using protected technology. Once those protections ended, rival manufacturers gained greater freedom to sell compatible pods, including products priced below Keurig-branded K-Cups.

The plaintiffs say Keurig responded to that new competition by using agreements with roasters, suppliers and distributors to preserve its market position. Their claims under the Sherman Act and Clayton Act focus on whether those contracts restrained trade or helped Keurig maintain monopoly power through exclusionary conduct after patent law no longer gave it the same ability to keep compatible pods out of the market.

The multidistrict litigation includes claims from several businesses, among them Rogers Family Coffee, the California company behind San Francisco Bay Coffee, and private-label manufacturer TreeHouse Foods. They say Keurig’s contracts restricted access to roasters, suppliers and distribution channels that competing pod makers needed to reach customers. Broderick found enough evidence for a jury to consider whether the combined agreements substantially shut rivals out of the market.

Some distributor agreements raise a separate tying issue. The plaintiffs say Keurig used its strength in commercial brewing equipment to influence customers’ pod purchases, and Broderick found enough factual disputes over whether those arrangements improperly linked the two products for the claim to continue.

Rogers Family Coffee can also pursue false-advertising claims over statements Keurig allegedly made about competing pods. Rogers says Keurig questioned the compatibility or performance of lower-priced alternatives in ways that could discourage consumers and businesses from buying them.

Broderick narrowed the case in several other areas. He rejected claims involving Keurig’s 2.0 brewer redesign, certain retail agreements, alleged patent misuse and acquisitions of rival coffee roasters. Although the 2.0 machines blocked some competing pods, the judge found the plaintiffs had not shown the coercion required for that theory, pointing in part to the continued availability of older Keurig 1.0 brewers.

Keurig’s earlier patent lawsuits produced a different result as well. Broderick found those infringement cases had an objective legal basis, leaving the surviving antitrust fight focused more heavily on Keurig’s commercial agreements after the key K-Cup patents expired.

More than $1.5 billion remains at stake across the surviving older cases, according to Keurig Dr Pepper’s regulatory disclosures. The figure represents damages claimed by multiple plaintiffs rather than a court award or a single demand by Rogers Family Coffee. Keurig disputes both liability and the amounts sought.

The plaintiffs contend that Keurig’s post-patent agreements reduced competition and kept K-Cup-compatible products more expensive than they would have been in a more open market. After years of consolidated pretrial litigation, Broderick has directed parties in one related case to discuss trial arrangements by November 16 and submit a proposed schedule by December 7. Proceedings in New York could begin in the second quarter of 2027, although no trial date has been set.